Tumor screening and biology in malignant melanomas

2012-11-16T11:09:22Z (GMT) by Salvador J. Diaz-Cano L Pozo-Garcia
<p>An Arch Dermatol article and editorial that emphasize the increasing incidence of thin malignant melanomas (MMs).<sup><a href="http://archderm.jamanetwork.com/article.aspx?articleid=190368#ref-dlt0700-3-1-1">1 </a></sup><sup>- <a href="http://archderm.jamanetwork.com/article.aspx?articleid=190368#ref-dlt0700-3-1-1">2 </a></sup> Similar results have been reported in different institutions,<sup><a href="http://archderm.jamanetwork.com/article.aspx?articleid=190368#ref-dlt0700-3-1-2">2 </a></sup> and that is certainly our experience as well. The analysis of those data highlights interrelated aspects of public health (screening) and tumor biology that are considered in the attached paper.<br></p>